• Home  /
  • Research & Analysis   /
  • WallStreet Performers of the Day: Emerson Electric Co. (NYSE:EMR), Array BioPharma Inc. (NASDAQ:ARRY)

WallStreet Performers of the Day: Emerson Electric Co. (NYSE:EMR), Array BioPharma Inc. (NASDAQ:ARRY)

Emerson Electric Co. (NYSE:EMR)

The shares of Emerson Electric Co. (NYSE:EMR) started off the last trading session with the price of $70.28 while closing the day with the price of $68.77. The shares of Emerson Electric Co. (NYSE:EMR) Fell -3.35% with the Loss of -1.51 points.

The shares of Emerson Electric Co. (NYSE:EMR) traded with the day volume of 3.15 Million shares whereas its average trading volume is 3.52 Million.

While analyzing the past performance of the stock we can see that the shares of Emerson Electric Co. (NYSE:EMR) Loss -3.05% in the last week while Falling -4.23% in the last month. Past quarter performance shows the green light with 0.34%. The semi-annual and annual performance shows 7.64% and 16.32% respectively.

Some critical values of the shares of Emerson Electric Co. (NYSE:EMR) to be discussed here are: the beta which shows the value at 1.17 while Average True Range of Emerson Electric Co. (NYSE:EMR) demonstrate the value at 1.58. The weekly and monthly volatility of the shares of Emerson Electric Co. (NYSE:EMR) are indicated at 2.18% and 1.99%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 40.42.

While studying the financial position of the shares of Emerson Electric Co. (NYSE:EMR), we can see that the Market capitalization of the company is at 43.89 Billion. The shares outstanding for the company is 638.2 Million and the shares float stands at 630.83 Million. The income of the company stand at 1.63 Billion while the sales stand at 15.86 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 2.54, Price to Earnings or P/E is at 27.13, Price to Sales P/S show the value of 2.77, the Return on Asset ROA stood at 0 and the Return on Equity ROE depicted at 0 while Return on Investment ROI is at 0.137.


Array BioPharma Inc. (NASDAQ:ARRY)

Array BioPharma Inc. (NASDAQ:ARRY) started its previous trading session at $16.71 and closed at $16.35 showing a Fell of -2.68 Percent.

The Company traded with an average Volume of 4 Million whereas, its Day Volume stood at 3.14 Million.

Looking at the performance of the stock, Array BioPharma Inc. (NASDAQ:ARRY) Loss -6.52% in the last week in its shares price and -7.42% in the last month. Quarterly performance shows a green of 50.41 Percent while Semi-Annual and Annual performances shows a 40.95 and 74.31 percent respectively.

Beta for Array BioPharma Inc. (NASDAQ:ARRY) stands at 1.7 while the ATR (average true range) is at 0.72. The Stock’s Weekly and Monthly Volatility is 4.57% and 3.92% respectively showing a RSI value of 40.93.

While studying the financial position of the shares of Array BioPharma Inc. (NASDAQ:ARRY), we can see that the Market capitalization of the company is at 3.53 Billion. The shares outstanding for the company is 215.78 Million and the shares float stands at 206.5 Million.

The Company generated an income of -137000000 and the sales of 139 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.77 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 25.38 respectively.

The Return on Assets stands at -0.365, ROE shows a value of -1.078 and ROI for Array BioPharma Inc. (NASDAQ:ARRY) is -0.711 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment